Answers are grounded in this paper and cite their sources.
A new metal organic framework (MOF) built up from non-toxic iron and the therapeutically active linker nicotinic acid, with pellagra-curative, vasodilating, and antilipemic properties, has been isolated and characterised via single crystal methods. The release of the therapeutic agent, which is a constituent of the framework, is achieved through the degradation of the hybrid phase, under simulated physiological conditions, allowing for the delivery of the bioactive molecule.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: